All Posts Tagged With: "BDX"
(MASI) Masimo Analysts Maintain Neutral Rating
We continue to maintain our ‘Neutral’ rating on Masimo Corp. (MASI) with a target price of $28 based on a P/E of 28.0x our fiscal 2010 EPS estimate of $1. The company’s fourth quarter fiscal 2009 results...
(BDX) Becton, Dickinson and Company Recalls Catheters
Becton, Dickinson and Company (BDX) recently started expanding the recall of its catheters as a result of a manufacturing problem that could cause fatal embolisms or blood leakage. Becton is recalling its...
(BAX) Baxter International Downgraded to Neutral
We recently downgraded Baxter International Inc. (BAX) to Neutral. The stock was assigned a target price of $59 based on an approximate P/E multiple of 13.9x our fiscal 2010 earnings estimate of $4.25.
Baxter...
(BDX) Becton, Dickinson and Company Beats Expectations – Bumps Estimates
We recently reiterated our Neutral rating on Becton, Dickinson and Company (BDX) with a target price of $78 based on a P/E of approximately 15.3x our fiscal 2010 EPS estimate of $5.10.
Becton recently...
(MDRX) Medical Devices Stock Review – Feburary 2010 – Industry Outlook
The global medical devices industry is fairly large, with annual worldwide sales in excess of $200 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different categories such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic...
(BDX) Becton Dickinson and Company Surpasses Consensus Estimates
Becton, Dickinson and Company (BDX) reported first quarter fiscal 2010 earnings per share of $1.30, surpassing the Zacks Consensus Estimate of $1.20 and the year-ago earnings of $1.25.
Total...
(BAX) Baxter International Reports Earnings In-Line
Baxter International Inc. (BAX) reported financial results for the fourth quarter and full fiscal 2009. For the fourth quarter, earnings per share were $1.03, in line with the Zacks Consensus Estimate and...
(MASI) Masimo Corporation Announces Positive Results From Clinical Study
Masimo Corporation (MASI) recently announced positive results form its 21-month clinical study on the impact of the Masimo Patient SafetyNet remote monitoring and clinician notification system. Results indicated...
(MASI) Masimo Corporation Can Now Earn While Patients Test Device Effectiveness
Masimo Corporation (MASI) has recently received a new Current Procedural Terminology (CPT) code from the American Medical Association, 88738, for its noninvasive hemoglobin (SpHb) measurement. Medicare has...
(MASI) Masimo Corporation in Expansion Mode
Masimo Corp. (MASI) recently announced the expansion of its corporate campus in Irvine, California with the addition of an adjacent 32,000 sq. ft. building. This is the company’s third building on...
(MASI) Masimo Completes Conversion of New Customer
Masimo Corp. (MASI) reported that its new customer, Brookdale University Hospital and Medical Center in Brooklyn, New York, has completed its system-wide conversion to Masimo SET pulse oximetry technology....
(BDX) Becton, Dickinson and Co Receives FDA Clearance
Becton, Dickinson and Co. (BDX) recently announced that BD Diagnostics, a segment of BDX, has received U.S. Food and Drug Administration (FDA) clearance to utilize its BD ProbeTec Chlamydia trachomatis (CT)...
(BAX) Baxter International Gets H1N1 Vaccine Order
Baxter International Inc. (BAX) recently received another order for 10,000 H1N1 vaccines, commonly known as “swine flu,” from Slovenia. The order is worth $158,700 (105,000 euros). It is estimated...
(MASI) Masimo Corporation Earns FDA New Product Approval
Masimo Corporation (MASI) recently received the U.S. Food and Drug Administration (FDA) approval for its new product, Masimo Rainbow SET Acoustic Monitoring. The new product enables noninvasive and continuous...
(MASI) Masimo Corporation Renews Deal with Advocate Health Care
Masimo Corporation (MASI) announced that one of its prominent customers, Advocate Health Care, has recently renewed its multi-year, system-wide contract for Masimo SET pulse oximetry technology. Advocate...
(BDX) Becton, Dickinson and Company Acquires HandyLab
Becton, Dickinson and Company (BDX) recently completed the acquisition of HandyLab, Inc, an Ann Arbor, Michigan-based company that develops and manufactures automation platforms and molecular diagnostic assays....
(CFN) CareFusion Corporation Enters Agreement with Masimo
CareFusion Corp. (CFN) entered into a multi-year technology licensing agreement with Masimo Corp. (MASI) regarding the use of Masimo Rainbow...
(BDX) Becton, Dickinson and Co Reports Strong Results
Becton, Dickinson and Co. (BDX) reported strong fourth quarter and full fiscal 2009 results. For the fourth quarter, earnings per share were $1.25, beating the Zacks Consensus...
(BDX) Becton-Dickinson and Company Set for Acquisition of HandyLab
Becton-Dickinson and Company (BDX) is set to acquire HandyLab Inc., an Ann Arbor, Michigan-based company that develops and manufactures automation platforms and molecular diagnostic assays....
(BAX) Baxter International Eyes Swine Flu Market
Baxter International Inc. (BAX) announced that it sees multiyear opportunity in H1N1 vaccines, commonly known as Swine Flu vaccines. The company expects to recognize $30 million to $40 million in revenues from swine flu vaccines in the fourth quarter. Baxter...
(MDRX) Medical Devices – Industry Outlook
The global medical devices industry is fairly large and is valued at roughly $223 billion, with the U.S. accounting for approximately 41%. The industry is divided into different categories such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT.
In...
(BAX) Baxter International Beats Earnings, Raises Outlook
Baxter International Inc. (BAX) today reported third quarter fiscal 2009 earnings per share of 98 cents, surpassing the Zacks Consensus Estimate of 97 cents and the year-ago earnings of 88 cents. The company also raised its outlook for full fiscal 2009.
(BDX) Becton, Dickinson and Co. Receives FDA Approval on Blood Collection Device
Becton, Dickinson and Co. (BDX) announced that it received Food and Drug Administration (FDA) approval to market its blood collection device, BD Vacutainer Rapid Serum Tube, in the U.S. Unlike standard tubes, the Serum tubes are ready for analysis in five...
(BAX) Baxter International Gets H1N1 Authorization
Baxter International Inc. (BAX) recently received marketing authorization for CELVAPAN H1N1 vaccine, commonly known as the Swine Flu vaccine, in the European Union. The company has already delivered limited quantities of H1N1 vaccine to a few countries, such...
(STJ) St. Jude Medical’s Results Disappoint
St. Jude Medical (STJ) warned that third-quarter earnings will be below previous guidance. The company anticipates reporting profits of 57 to 58 cents per share, compared to prior guidance of 61 to 63 cents and the Zacks Consensus Estimate of 62 cents. St....
(BAX) Baxter International’s H1N1 Vaccine Gets a Boost
Baxter International Inc. (BAX) announced that the European Medicines Agency (EMEA) opined positively for Baxter’s CELVAPAN H1N1 pandemic vaccine, commonly known as the Swine Flu vaccine.
This is a boost for Baxter’s regulatory submission to obtain...
(BAX) Baxter International Discussed Long-Term Goals
Baxter International Inc. (BAX) discussed its long-term financial objectives, growth opportunities and various research and development (R&D) programs at its recently concluded Investor Conference in Chicago.
The long-term (5-year) financial objectives...
(BAX) Baxter International Fails to Deliver Swine Flu Vaccine
Baxter International Inc. (BAX) has failed to deliver on its pledge to the U.K. government to supply required quantities of swine flu vaccine, Celvapan. The company has supplied only half of the 400,000 doses of Celvapan it had agreed to supply by the end...
(BDX) Becton, Dickinson and Company Receives $52 Million Government Order
Becton, Dickinson and Company (BDX) received an order from the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) for the purchase of syringes and needles, sharps collectors and alcohol...
(EMS) Masimo Corporation signed agreement with German company
Masimo Corporation (MASI) announced that it has signed a new worldwide technology licensing agreement with GS Elektromedizinische Gerate G. Stemple GmbH that will enable the latter to integrate Masimo’s Rainbow SET Pulse CO-Oximetry into its corpuls patient...